Antiplatelets in secondary stroke prevention: Should clopidogrel be the first choice?

Postgraduate Medical Journal

Volumn 88, Issue 1035, 2012, Pages 34-37

  Darren, A W ^a   Sharma, Jagdish C ^a,b  

^a LINCOLN COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE;

ANTICOAGULANT THERAPY; BLEEDING; CEREBROVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); DIARRHEA; DIZZINESS; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL HEMORRHAGE; HEART PALPITATION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MONOTHERAPY; REVIEW; STROKE; SYSTEMATIC REVIEW (TOPIC); TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; UNSPECIFIED SIDE EFFECT;

ASPIRIN; DIPYRIDAMOLE; HUMANS; ISCHEMIA; ISCHEMIC ATTACK, TRANSIENT; PLATELET AGGREGATION INHIBITORS; SECONDARY PREVENTION; STROKE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 83755195642     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2011-130100     Document Type: Review

References (25)

1. Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238-1251.
2. Shinohara Y, Katayama Y, Uchiyama S, et al. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, doubl-blind, randomised non-inferiority trial. Lancet Neurol 2010;9:959-968.
3. Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke 2000;31:1240-1249.
4. Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-1860.
5. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
6. Halkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665-1673.
7. Hass WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989;321:501-507.
8. Gorelick PB, Richardson D, Kelly M, et al. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003;289:2947-2957.
9. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
10. Sudlow CL, Mason G, Maurice JB, et al. Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database Syst Rev 2009;(4):CD001246.
11. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, doubl-blind, placebo-controlled trial. Lancet 2004;364:331-337.
12. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-1717.
13. Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection. The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial. Circulation 2005;111:2233-2240.
14. Stroke Trials RegistrydTriple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS). 2010. http://www.strokecenter.org/trials/TrialDetail.aspx?tid=959 (accessed 8 Jul 2011).
15. Sharma JC, Vassallo M, Ross IN. ProFESS trial: any lessons to learn for future antiplatelet trials? Int J Stroke 2009;4:458-460.
16. Bath PM, Cotton D, Martin RH, et al. Effect of combined aspirin and extendedrelease dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke 2010;41:732-738.
17. Gongora-Rivera F, Labreuche J, Jaramillo A, et al. Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke 2007;38:1203-1210.
18. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Fiv-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000;31:2080-2086.
19. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
20. Diener HC, Sacco R, Yusuf S. Rationale, design and baseline data of a randomized, doubl-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis 2007;23:368-380.
21. Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain 2005;128:2507-2517.
22. Albers GW, Amarenco P. Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascular patients? Stroke 2001;32:2948-2949.
23. NICE TA210 Vascular diseasedclopidogrel and dipyridamole: Guidance. 2010. http://www.nice.org.uk/guidance/TA210 (accessed 3 Dec 2010).
24. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:227-276.
25. European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507. http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=131083&Ausgabe= 235865&ProduktNr=224153&filename=131083.pdf (accessed 3 Dec 2010).